These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 4138389)

  • 1. Letter: Serum-creatine-kinase levels in carriers of Becker muscular dystrophy.
    Skinner R; Emery AE
    Lancet; 1974 Oct; 2(7887):1023-4. PubMed ID: 4138389
    [No Abstract]   [Full Text] [Related]  

  • 2. The detection of carriers of benign (Becker-type) X-linked muscular dystrophy.
    Skinner R; Emery AE; Anderson AJ; Foxall C
    J Med Genet; 1975 Jun; 12(2):131-4. PubMed ID: 1142377
    [No Abstract]   [Full Text] [Related]  

  • 3. Variability of serum creatine phosphokinase activity in normal women and carriers of the gene for Duchenne muscular dystrophy.
    Perry TB; Fraser FC
    Neurology; 1973 Dec; 23(12):1316-23. PubMed ID: 4796611
    [No Abstract]   [Full Text] [Related]  

  • 4. [Genetics of muscular dystrophies].
    Harper PS
    Recenti Prog Med; 1977 May; 62(5):489-511. PubMed ID: 329369
    [No Abstract]   [Full Text] [Related]  

  • 5. Carrier detection in Duchenne muscular dystrophy: Assessment of the effect of age on detection-rate with serum-creatine-kinase-activity.
    Nicholson GA; Gardner-Medwin D; Pennington RJ; Walton JN
    Lancet; 1979 Mar; 1(8118):692-4. PubMed ID: 85935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of creatine kinase for detecting severe X-linked muscular dystrophy carriers.
    Dennis NR; Evans K; Clayton B; Carter CO
    Br Med J; 1976 Sep; 2(6035):577-9. PubMed ID: 963439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of carriers and genetic counseling in duchenne muscular dystrophy by ribosomal protein synthesis.
    Ionasescu V; Zellweger H; Burmeister L
    Acta Neurol Scand; 1976 Nov; 54(5):442-52. PubMed ID: 998168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carrier detection in Becker muscular dystrophy using creatine kinase estimation and DNA analysis.
    Kingston HM; Sarfarazi M; Newcombe RG; Willis N; Harper PS
    Clin Genet; 1985 Apr; 27(4):383-91. PubMed ID: 3995787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter: Follow-up study of serum-creatine-kinase in carriers of Duchenne muscular dystrophy.
    Moser H; Vogt J
    Lancet; 1974 Sep; 2(7881):661-2. PubMed ID: 4137773
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of serum creatine phosphokinase in genetic counseling for Duchenne muscular dystrophy. I. Analysis of results from 29 studies.
    Gale AN; Murphy EA
    J Chronic Dis; 1978 Feb; 31(2):101-9. PubMed ID: 659567
    [No Abstract]   [Full Text] [Related]  

  • 11. Carrier detection and genetic counselling in Duchenne dystrophy.
    Dubowitz V
    Dev Med Child Neurol; 1975 Jun; 17(3):352-6. PubMed ID: 1107098
    [No Abstract]   [Full Text] [Related]  

  • 12. [Biochemical, histological and clinical findings in carriers of Duchenne-type progressive muscular dystrophy].
    Moser H; Mumenthaler M; Wiesmann U
    Schweiz Med Wochenschr; 1971 Apr; 101(15):537-42. PubMed ID: 5576948
    [No Abstract]   [Full Text] [Related]  

  • 13. Creatine phosphokinase in facioscapulohumeral muscular dystrophy.
    Hughes BP
    Br Med J; 1971 Aug; 3(5772):464-5. PubMed ID: 5567771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum creatine kinase studies in the detection of carriers of Duchenne dystrophy.
    Hughes RC; Park DC; Parsons ME; O'Brien MD
    J Neurol Neurosurg Psychiatry; 1971 Oct; 34(5):527-30. PubMed ID: 4941478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The contribution of assays for lymphocyte capping and creatine kinase to detection of the Becker-type dystrophy trait.
    Goldsmith BM; Gruemer HD; Hawley RJ; Pickard NA; Verrill HL; Nance WE; Miller G; Crawford RG
    Clin Chem; 1980 May; 26(6):754-9. PubMed ID: 7371153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic delay in Duchenne's muscular dystrophy.
    Crisp DE; Ziter FA; Bray PF
    JAMA; 1982 Jan 22-29; 247(4):478-80. PubMed ID: 7054550
    [No Abstract]   [Full Text] [Related]  

  • 17. Genetic counseling in Duchenne muscular dystrophy.
    Bradley WG; Kelemen J
    Muscle Nerve; 1979; 2(5):325-8. PubMed ID: 492208
    [No Abstract]   [Full Text] [Related]  

  • 18. The detection of female carriers of pseudohypertrophic muscular dystrophy.
    Kakulas BA; Knight JO; Gubbay SS; Mastaglia FL
    Proc Aust Assoc Neurol; 1968; 5(3):545-51. PubMed ID: 5709982
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum LDH-5 in carriers of Duchenne muscular dystrophy.
    Burt D; Emery AE
    Neurology; 1979 Feb; 29(2):239-41. PubMed ID: 571069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscular dystrophy: diagnosis and treatment.
    Ketenjian AY
    Orthop Clin North Am; 1978 Jan; 9(1):25-42. PubMed ID: 643265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.